The Journal of pharmacy and pharmacology · 2026
Qian Yang Yu Yin Granule ameliorates hypertension-induced renal injury through the modulation of oxidative stress via Sestrin2 signaling pathway.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Qian Lichao, Shen Shuang, Yang Ying, Qin Bin, Ren Shuai, Wu Lihua
Аннотация
OBJECTIVE: This study investigated the protective mechanisms of Qian Yang Yu Yin Granule (QYYYG) against hypertensive renal injury.
METHODS: A hypertensive renal injury model was established in Spontaneous hypertensive rat (SHR) rats using angiotensin II infusion combined with unilateral nephrectomy. Rats were assigned to model, valsartan, and high-/low-dose QYYYG groups and treated for 8 weeks. Blood pressure (BP), blood urea nitrogen (BUN), renal histopathology, and related biochemical indicators were evaluated. In vitro, HK-2 cells pretreated with QYYYG or valsartan were subjected to hypoxic conditions. The expression levels of HIF-1α, NOX4, HO-1, Nrf2, and SESN2 were quantified.
KEY FINDINGS: QYYYG markedly reduced BP and BUN levels and ameliorated renal histopathological damage. It upregulated SESN2, activated AMPKα, inhibited mTOR phosphorylation, and suppressed NOX4 expression, thereby reducing HIF-1α accumulation. QYYYG also enhanced the expression of SESN2, Nrf2, and HO-1. Consistently, in vitro, QYYYG significantly increased SESN2, Nrf2, and HO-1 expression while reducing NOX4 and HIF-1α levels.
CONCLUSION: QYYYG alleviates hypertensive renal injury by regulating the Sestrin2 signaling pathway and improving local oxidative stress responses.
METHODS: A hypertensive renal injury model was established in Spontaneous hypertensive rat (SHR) rats using angiotensin II infusion combined with unilateral nephrectomy. Rats were assigned to model, valsartan, and high-/low-dose QYYYG groups and treated for 8 weeks. Blood pressure (BP), blood urea nitrogen (BUN), renal histopathology, and related biochemical indicators were evaluated. In vitro, HK-2 cells pretreated with QYYYG or valsartan were subjected to hypoxic conditions. The expression levels of HIF-1α, NOX4, HO-1, Nrf2, and SESN2 were quantified.
KEY FINDINGS: QYYYG markedly reduced BP and BUN levels and ameliorated renal histopathological damage. It upregulated SESN2, activated AMPKα, inhibited mTOR phosphorylation, and suppressed NOX4 expression, thereby reducing HIF-1α accumulation. QYYYG also enhanced the expression of SESN2, Nrf2, and HO-1. Consistently, in vitro, QYYYG significantly increased SESN2, Nrf2, and HO-1 expression while reducing NOX4 and HIF-1α levels.
CONCLUSION: QYYYG alleviates hypertensive renal injury by regulating the Sestrin2 signaling pathway and improving local oxidative stress responses.